Katsuhiko Matsui, Yuki Nojima, Yuka Kajiwara, Kana Busujima, & Yuki Mori. (2020). Topical Application of Doxycycline Inhibits Th2 Cell Development Mediated by Langerhans Cells and Exerts a Therapeutic Effect on Atopic Dermatitis. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKatsuhiko Matsui, Yuki Nojima, Yuka Kajiwara, Kana Busujima, and Yuki Mori. Topical Application of Doxycycline Inhibits Th2 Cell Development Mediated by Langerhans Cells and Exerts a Therapeutic Effect on Atopic Dermatitis. Frontiers Media S.A., 2020.
MLA (9th ed.) CitationKatsuhiko Matsui, et al. Topical Application of Doxycycline Inhibits Th2 Cell Development Mediated by Langerhans Cells and Exerts a Therapeutic Effect on Atopic Dermatitis. Frontiers Media S.A., 2020.
Warning: These citations may not always be 100% accurate.